These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4898403)
1. Chemotherapeutic trials in leprosy. 6. Pilot study of the riminophenazine derivative B.663 in low dosage (100 mgm. twice weekly) in the treatment of lepromatous leprosy. Waters MF Int J Lepr Other Mycobact Dis; 1968; 36(4):391-9. PubMed ID: 4898403 [No Abstract] [Full Text] [Related]
2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]
3. Chemotherapeutic trials in leprosy. 7. Trial of 50 mgm. DDS twice weekly in the treatment of lepromatous leprosy. Pearson JM; Pettit JH Int J Lepr Other Mycobact Dis; 1969; 37(1):40-5. PubMed ID: 4897238 [No Abstract] [Full Text] [Related]
4. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy. Waters MF; Rees RJ; Sutherland I Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107 [No Abstract] [Full Text] [Related]
5. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study. Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958 [No Abstract] [Full Text] [Related]
6. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance. Pearson JM; Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115 [No Abstract] [Full Text] [Related]
7. Effect of B.1912, a new riminophenazine derivative in murine leprosy. Chang YT Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494 [No Abstract] [Full Text] [Related]
8. Clofazimine (Lamprene) in leprosy. Drug Ther Bull; 1970 Jan; 8(2):7-8. PubMed ID: 4903794 [No Abstract] [Full Text] [Related]
9. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases. Koticha KK; Sane AB Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310 [No Abstract] [Full Text] [Related]
10. [2 cases of paucibacillary leprosy resistant to dapsone]. Janssens L Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of lepromatous leprosy by ethionamide]. Rollier R; Rollier M Maroc Med; 1972 Mar; 52(555):148-66. PubMed ID: 4261347 [No Abstract] [Full Text] [Related]
12. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663). Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070 [No Abstract] [Full Text] [Related]
17. Primary dapsone resistant leprosy in Nepal. Samuel NM; Samuel S; Loudon J; Adiga RB Indian J Lepr; 1984; 56(4):819-22. PubMed ID: 6398343 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy. Waters MF; Pettit JH Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767 [No Abstract] [Full Text] [Related]
19. Further studies on B.663 in murine leprosy. Absence of resistance of M. lepraemurium to B.663 and delay in development of resistance to isoniazid. Chang YT Int J Lepr Other Mycobact Dis; 1966; 34(1):1-6. PubMed ID: 5327050 [No Abstract] [Full Text] [Related]
20. The treatment of erythema nodosum leprosum with B.663. A controlled study. Pettit JH Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017 [No Abstract] [Full Text] [Related] [Next] [New Search]